New mutation in the desmoplakin gene leads to ACM
Researchers from the group of Eva van Rooij in collaboration with the UMC Utrecht identified a new mutation that leads to the cardiac disease arrhythmogenic cardiomyopathy (ACM). They assessed the effect of this mutation on heart muscle cells and obtained new insights into the underlying mechanism that causes the disease. The results of this study, published on March 2nd in Stem Cell Reports, could contribute to the development of new treatments for ACM.
Desmosomes
Millions of heart muscle cells contract to let the heart fulfill ...
















